- Home
- GENC vs CATX Comparison
GENC vs CATX Comparison
Compare GENC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENC | CATX |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 211.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GENC | CATX |
|---|---|---|
| Price | $13.53 | $4.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $16.00 | $11.56 |
| AVG Volume (30 Days) | 27.1K | ★ 1.1M |
| Earning Date | 12-09-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.92 | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $115,437,000.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.66 | ★ N/A |
| Revenue Growth | ★ 2.01 | N/A |
| 52 Week Low | $10.80 | $1.60 |
| 52 Week High | $17.40 | $5.39 |
Technical Indicators
Market Signals| Indicator | GENC | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 78.17 |
| Support Level | $13.34 | $2.55 |
| Resistance Level | $14.13 | $2.78 |
| Average True Range (ATR) | 0.39 | 0.46 |
| MACD | -0.04 | 0.12 |
| Stochastic Oscillator | 32.55 | 59.59 |
Price Performance
Historical ComparisonAbout GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.